|
|
Volumn 16, Issue 12, 1995, Pages 401-404
|
|
Pharmacological inhibition of restenosis: learning from experience
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID;
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ARGININE;
BRADYKININ B2 RECEPTOR ANTAGONIST;
CILAZAPRIL;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN 1;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ENDOTHELIN RECEPTOR ANTAGONIST;
HEPARIN;
HIRUDIN;
HIRULOG;
ICATIBANT;
LOW MOLECULAR WEIGHT HEPARIN;
MONOCLONAL ANTIBODY;
N(G) NITROARGININE METHYL ESTER;
NOLSIDOMINE;
PHOSPHODIESTERASE INHIBITOR;
SC 48936;
SPIRAPRIL;
TICK ANTICOAGULANT PEPTIDE;
TRAPIDIL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VASOACTIVE AGENT;
ANIMAL MODEL;
ARTERY INTIMA PROLIFERATION;
BALLOON DILATATION;
CLINICAL TRIAL;
CORONARY ARTERY OBSTRUCTION;
HEMODYNAMICS;
HUMAN;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
RESTENOSIS;
REVIEW;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMAL;
AORTIC VALVE STENOSIS;
DISEASE MODELS, ANIMAL;
ENDOTHELIUM, VASCULAR;
HUMAN;
RABBITS;
RATS;
RISK FACTORS;
SUPPORT, NON-U.S. GOV'T;
VASOCONSTRICTION;
|
|
EID: 0028863534
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(00)89085-9 Document Type: Article |
|
Times cited : (21)
|
|
References (36)
|
